About
26 Therapeutics Inc. is a Montréal-based life sciences company developing first-in-class therapies for dry eye disease and meibomian gland disorders.
Explore 26Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.